40323-TS-Amgen-LabTalk-2p

Undruggable - A special 5-part podcast series

Welcome to Undruggable, a special edition podcast series produced by The Scientist’s Creative Services Team.

This series is brought to you by Amgen, a pioneer in the science of using living cells to make biologic medicines. They helped invent the processes and tools that built the global biotech industry, and have since reached millions of patients suffering from serious illnesses around the world with their medicines.

Beginning with the introduction of aspirin at the start of the 20th century, there have been three major waves of innovation in drug discovery. While breakthrough discoveries have been made, 85% of disease targets are still considered undruggable, which represents an ongoing barrier to discovering medicines for complex diseases like cancer and autoimmune conditions. Ray Deshaies, who has spent decades in academic research and is a senior vice president at Amgen, believes that the fourth wave of innovation is here, led by new types of multispecific medicines that will radically alter our concept of how drugs can work and pave the way for new solutions.

Sign up now to receive an email when each podcast episode airs.

  • Episode 1 - The Next Wave of Drug Development
    October 21, 2021
  • Episode 2 - Drugging the Undruggable: The Biology of PROTACs
    October 28, 2021
  • Episode 3 - Discovery at the DNA Encoded Library
    November 4, 2021
  • Episode 4 - The Emerging Induced Proximity Toolkit
    November 11, 2021
  • Episode 5 - Induced Proximity for Cancer and Beyond
    November 18, 2021
Visit this page to sign up for the Undruggable Q&A series, airing soon!
  • Webinar 1 - The Next Wave of Drug Development and Drugging the Undruggable: The Biology of PROTACs
    November 3, 2021
  • Webinar 2 - Discovery at the DNA Encoded Library
    November 10, 2021
  • Webinar 3 - The Emerging Induced Proximity Toolkit
    November 17, 2021

 

 

Host

Deshaies
Ray Deshaies, PhD
Senior Vice President
Global Research
Amgen

Sponsor

Amgen.png

Sign up and listen now

TS_Podcast_Amgen_Series 2_Undruggable_#403179


Information you provide will be held in confidence and will be shared with the sponsoring vendor(s) of this podcast. We may use the information to contact you about your account and to let you know about related programs and products; you may opt-out at any time. This allows The Scientist to keep these podcasts free of charge for our readers.